How Experts Treat Mantle Cell Lymphoma (with Prof Mats Jerkeman)
Get up to date with the latest EHA-EU guideline for Mantle Cell Lymphoma (EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma - Jerkeman - 2025 - HemaSphere - Wiley Online Library) with Prof Mats Jerkeman (Lund University, Sweden).
In this episode, he explains how biological risk factors, particularly TP53 mutations and proliferation rate, inform patient stratification. He reviews evolving treatment sequencing, including the expanding role of BTK inhibitors (such as ibrutinib) in first-line regimens.
He further discusses the management relapsed/refractory MCL…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.